Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Statistics

Total Valuation

KROS has a market cap or net worth of $576.39 million. The enterprise value is $35.32 million.

Market Cap	576.39M
Enterprise Value	35.32M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

KROS has 40.56 million shares outstanding. The number of shares has increased by 27.14% in one year.

Current Share Class	40.56M
Shares Outstanding	40.56M
Shares Change (YoY)	+27.14%
Shares Change (QoQ)	+7.31%
Owned by Insiders (%)	0.98%
Owned by Institutions (%)	82.46%
Float	30.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	149.86
Forward PS	91.64
PB Ratio	1.01
P/TBV Ratio	1.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.45, with a Debt / Equity ratio of 0.03.

Current Ratio	21.45
Quick Ratio	20.56
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.46% and return on invested capital (ROIC) is -28.12%.

Return on Equity (ROE)	-41.46%
Return on Assets (ROA)	-26.73%
Return on Invested Capital (ROIC)	-28.12%
Return on Capital Employed (ROCE)	-35.83%
Revenue Per Employee	$21,006
Profits Per Employee	-$1.11M
Employee Count	169
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, KROS has paid $300,000 in taxes.

Income Tax	300,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.86% in the last 52 weeks. The beta is 1.39, so KROS's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	-74.86%
50-Day Moving Average	11.50
200-Day Moving Average	35.73
Relative Strength Index (RSI)	68.53
Average Volume (20 Days)	1,552,111

Short Selling Information

The latest short interest is 4.41 million, so 10.87% of the outstanding shares have been sold short.

Short Interest	4.41M
Short Previous Month	4.05M
Short % of Shares Out	10.87%
Short % of Float	14.34%
Short Ratio (days to cover)	3.45

Income Statement

In the last 12 months, KROS had revenue of $3.55 million and -$187.35 million in losses. Loss per share was -$5.00.

Revenue	3.55M
Gross Profit	-14.74M
Operating Income	-210.83M
Pretax Income	-168.05M
Net Income	-187.35M
EBITDA	-209.60M
EBIT	-210.83M
Loss Per Share	-$5.00

Balance Sheet

The company has $559.93 million in cash and $18.86 million in debt, giving a net cash position of $541.07 million or $13.34 per share.

Cash & Cash Equivalents	559.93M
Total Debt	18.86M
Net Cash	541.07M
Net Cash Per Share	$13.34
Equity (Book Value)	571.55M
Book Value Per Share	14.09
Working Capital	561.44M

Cash Flow

In the last 12 months, operating cash flow was -$160.87 million and capital expenditures -$1.93 million, giving a free cash flow of -$162.80 million.

Operating Cash Flow	-160.87M
Capital Expenditures	-1.93M
Free Cash Flow	-162.80M
FCF Per Share	-$4.01

Margins

Gross Margin	n/a
Operating Margin	-5,938.96%
Pretax Margin	-5,269.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KROS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.14%
Shareholder Yield	n/a
Earnings Yield	-32.50%
FCF Yield	-28.24%

Analyst Forecast

The average price target for KROS is $25.29, which is 77.97% higher than the current price. The consensus rating is "Buy".

Price Target	$25.29
Price Target Difference	77.97%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	103.55%
EPS Growth Forecast (5Y)	-15.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KROS has an Altman Z-Score of 25.23 and a Piotroski F-Score of 3.

Altman Z-Score	25.23
Piotroski F-Score	3